Skip to main content
OpenTrials
Completed

NCT Number: NCT02835989

Community Paramedicine at Home

Community Paramedicine @Home (CP@Home) is a novel community paramedicine health assessment program for high users of Emergency Medical Services (EMS). Individuals who have been identified as active callers to EMS, individuals who have called EMS for lift-assists, and direct paramedic referrals are referred into the community paramedicine home visit program. The program will focus on in-home chronic disease management, community health service connections, and EMS usage education. Aside from chronic disease management, aspects of the program include health-related quality of life, social isolation and other social determinants of health. Participants in the program will have up to 3 one-on-one home visits from a community paramedic to ultimately reduce repeat EMS calls and improve their overall health.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

McMaster University

Hamilton, Ontario, L8S4K1, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 3 or more EMS calls in the last 6 months from intervention start date AND active caller in the last 30 days OR
  • Any call for a lift assist to EMS in the past 30 days OR
  • Paramedic referral into program (identified by paramedic through usual practice)

Exclusion criteria

  • Individuals living in long term care facilities
  • Individuals currently involved in a home visit or social navigator program

Treatment and study plan

CP@Home

Other

Community paramedics (CPs) will be assigned to visiting the participants for a first time the week following the initial EMS call. Participants will complete the informed consent process with a CP on their first visit. This visit will also include a full assessment and risk analysis that will take approximately 90 minutes and will be located in the participant's home. As a result of the initial visit, the CP will make all relevant clinical referrals and decisions based on predetermined @Home algorithms. A second visit will be made to the participant 2-4 weeks following the initial call for a streamlined follow-up and reassessment during a 30 minute period. A final visit will be made 6-8 weeks following the initial call for a final evaluation of their situation. It is anticipated the patient will be discharged from the CP@Home program at this point. If the patient calls EMS following the third visit, if they meet the inclusion criteria, they will be re-entered into the CP@Home program.

Primary outcomes

  1. Change in number of repeat EMS calls

    Time frame: Baseline and 1 year

    Individual-level change in EMS call rate resulting in ambulance dispatch (pre-post intervention)

Secondary outcomes

  1. Change in number of ED presentations

    Time frame: Baseline and 1 year

    Individual-level change in number of ED presentations (pre-post)

  2. Change in number of hospital admissions

    Time frame: Baseline and 1 year

    Individual-level change in number of hospital admissions (pre-post)

Sponsors and collaborators

Lead sponsor

McMaster University

Other

Registry information

Official study title

Community Paramedicine at Home (CP @Home)

Acronym: CP@Home

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Jul 18, 2016
Registry last updated
Sep 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.